Scientists test new drug cocktail to fight advanced skin cancer
NCT ID NCT03999749
Summary
This study is testing whether adding a drug called tocilizumab to two existing immunotherapy drugs (ipilimumab and nivolumab) is safe and effective for people with advanced melanoma that cannot be removed by surgery. The trial involves 71 participants and will measure side effects, how many people's tumors shrink, and how long the treatment keeps the cancer from getting worse. The goal is to see if this three-drug combination should be studied further in larger trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
The Angeles Clinic
Los Angeles, California, 90025, United States
Conditions
Explore the condition pages connected to this study.